Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 1 (RPL36P1) is a processed pseudogene that shares sequence similarity with the protein-coding gene RPL36, which encodes a structural protein component of the 60S subunit of the cytoplasmic ribosome[1][10]. Unlike functional genes, pseudogenes like RPL36P1 do not code for an active protein product. They typically arise through the retrotransposition of mRNA from the functional gene, becoming integrated into the genome as non-functional genomic sequences[4]. RPL36P1 has no confirmed protein product, established biological function, or role as a drug target, biomarker, or therapeutic receptor, and is not actively implicated in disease or cellular processes. Its significance is primarily evolutionary or as a genomic reference point for designing molecular biology probes to distinguish between functional RPL36 and its pseudogenes[4][1][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 1 (RPL36P1).